tirzepatide glucose variability
Tirzepatide Cuts Variability Semaglutide Costs More?
A recent crossover study demonstrates tirzepatide reduces postprandial glucose spikes by 32%, compared to 12% with semaglutide - an improvement that could shift treatment strategies. In my practice, this difference translates into steadier daily glucose curves and fewer emergency visits for patients battling obesity-related diabetes. Medical Disclaimer: This article is